IL6 and neoplasm: According to this study, synchronous ARID1A loss and PIK3CA overactivation synergistically induced upregulation of IL-6, a cytokine that triggers and is triggered by the JAK/STAT pathway, thereby initiating a signaling cycle that promotes tumor cell growth and differentiation [99,100].